Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Clinical Medicine School of Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Reprod Sci. 2024 Aug;31(8):2425-2432. doi: 10.1007/s43032-024-01530-x. Epub 2024 Apr 15.
This study aims to investigate the association between chromosomal polymorphisms and abnormalities in male reproductive health. Within the period from January 2018 to December 2022, a cohort of 10,827 males seeking fertility services at our reproductive center was selected for inclusion in this study. Peripheral blood chromosomal karyotype analysis was conducted for each participant to identify carriers of chromosomal polymorphisms, who were subsequently categorized into a polymorphism group. Additionally, a control group was constituted by randomly selecting 1,630 patients exhibiting normal chromosomal karyotypes. The study conducted statistical analyses to compare clinical outcomes between the two groups, focusing on infertility, history of spontaneous miscarriage in partners, anomalies in reproductive development, fetal abnormalities, and sperm quality metrics. (1) Among the cohort of 10,827 males, chromosomal polymorphisms were identified in 1,622 participants, yielding a detection rate of 14.98%. This rate is significantly elevated in comparison to the baseline prevalence of 1.77% observed in the general population. (2) The predominant variant among these polymorphisms was related to the Y chromosome, accounting for 1,082 cases (66.71% of the polymorphic findings), corresponding to a detection rate of 9.99%. This is markedly higher than the approximate 0.09% prevalence noted within a normative demographic. (3) Statistical analysis revealed significant disparities between the chromosomal polymorphism group and the control group in several clinical outcomes. Notably, the rates of spontaneous abortion (18.06% vs. 1.35%), fetal anomalies (1.97% vs. 0.25%), and poor sperm quality (41.74% vs. 7.18%) were markedly higher in the polymorphism group. Additionally, incidences of testicular dysgenesis (2.28% vs. 0.92%) and hypogonadism in partners (0.62% vs. 0.37%) also demonstrated significant differences, underscoring the potential reproductive implications of chromosomal polymorphisms. The study establishes a significant link between chromosomal polymorphisms and critical reproductive outcomes, including male infertility, spontaneous miscarriages in partners, fetal anomalies, and reduced sperm quality. These findings highlight the clinical relevance of chromosomal polymorphisms in reproductive health assessments and suggest the necessity for their consideration in the diagnostic and therapeutic strategies for male reproductive disorders.
本研究旨在探讨染色体多态性与男性生殖健康异常之间的关联。在 2018 年 1 月至 2022 年 12 月期间,我们的生殖中心招募了 10827 名寻求生育服务的男性,将其纳入本研究。对每位参与者进行外周血染色体核型分析,以确定染色体多态性携带者,随后将其分为多态性组。此外,还通过随机选择 1630 名具有正常染色体核型的患者组成对照组。研究对两组的临床结局进行了统计分析,重点比较了不孕、配偶自然流产史、生殖发育异常、胎儿异常和精子质量指标。(1) 在 10827 名男性中,发现 1622 名参与者存在染色体多态性,检出率为 14.98%。这一检出率明显高于一般人群中 1.77%的基线患病率。(2) 这些多态性中主要的变异与 Y 染色体有关,占 1082 例(多态性发现的 66.71%),检出率为 9.99%。这明显高于正常人群中约 0.09%的患病率。(3) 统计分析显示,染色体多态性组与对照组在几个临床结局方面存在显著差异。值得注意的是,自然流产率(18.06%比 1.35%)、胎儿异常率(1.97%比 0.25%)和精子质量差率(41.74%比 7.18%)在多态性组明显更高。此外,睾丸发育不良发生率(2.28%比 0.92%)和配偶低促性腺激素血症发生率(0.62%比 0.37%)也有显著差异,这突显了染色体多态性对生殖的潜在影响。本研究确立了染色体多态性与男性不育、配偶自然流产、胎儿异常和精子质量下降等关键生殖结局之间的显著关联。这些发现强调了染色体多态性在生殖健康评估中的临床意义,并表明在男性生殖障碍的诊断和治疗策略中需要考虑它们。